Botanix Pharmaceuticals Ltd
ASX:BOT

Watchlist Manager
Botanix Pharmaceuticals Ltd Logo
Botanix Pharmaceuticals Ltd
ASX:BOT
Watchlist
Price: 0.38 AUD 1.33% Market Closed
Market Cap: 742.5m AUD

Wall Street
Price Targets

BOT Price Targets Summary
Botanix Pharmaceuticals Ltd

Wall Street analysts forecast BOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOT is 0.66 AUD with a low forecast of 0.66 AUD and a high forecast of 0.68 AUD.

Lowest
Price Target
0.66 AUD
73% Upside
Average
Price Target
0.66 AUD
74% Upside
Highest
Price Target
0.68 AUD
80% Upside
Botanix Pharmaceuticals Ltd Competitors:
Price Targets
FULC
Fulcrum Therapeutics Inc
17% Downside
WVE
WAVE Life Sciences Ltd
239% Upside
IPN
Ipsen SA
25% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
11% Upside
RAPP
Rapport Therapeutics Inc
250% Upside
KLBF
Kalbe Farma Tbk PT
13% Upside

Revenue
Forecast

Revenue Estimate
Botanix Pharmaceuticals Ltd

The compound annual growth rate of Botanix Pharmaceuticals Ltd's revenue for the next 3 years is 675%.

N/A
Past Growth
675%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
29%
Average Beat

Net Income
Forecast

Net Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BOT's stock price target?
Price Target
0.66 AUD

According to Wall Street analysts, the average 1-year price target for BOT is 0.66 AUD with a low forecast of 0.66 AUD and a high forecast of 0.68 AUD.

What is Botanix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
675%

The compound annual growth rate of Botanix Pharmaceuticals Ltd's revenue for the next 3 years is 675%.

Back to Top